Simple Guide to Rebuilding Your Credit after Bankruptcy: Part Two

October 31, 2015

Simple Guide to Rebuilding Your Credit after Bankruptcy: Part Two

Note: This article is a continuation from Part One of the Simple Guide to Rebuilding Your Credit after Bankruptcy. Six Months after Discharge Apply... Read More

Fears | Nachawati Sponsors Parish Episcopal’s “Spooky Saturday”

Fears | Nachawati Sponsors Parish Episcopal’s “Spooky Saturday”

This past weekend, Fears | Nachawati Law Firm proudly sponsored Parish Episcopal School’s Spooky Saturday at the Parish Episcopal School in... Read More

Simple Guide to Rebuilding Your Credit after Bankruptcy: Part One

October 30, 2015

Simple Guide to Rebuilding Your Credit after Bankruptcy: Part One

This is a simple guide for rebuilding your credit after a bankruptcy discharge. Recovering from the effects of bankruptcy takes time and attention.... Read More

Power Morcellator Investigation Challenges FDA Approval of Dangerous Device

October 23, 2015

Power Morcellator Investigation Challenges FDA Approval of Dangerous Device

U.S. lawmakers are planning to launch an investigation into the FDA regulation of power morcellators. The U.S. Government Accountability Office has... Read More

IVC Filters Cause More Risks than Benefits

IVC Filters Cause More Risks than Benefits

Recently, the JAMA (The Journal of the American Medical Association) published an article concerning the use of IVC filters for pulmonary embolism... Read More

Xarelto Advertisements Failed to Disclose the Reality of Risks, Lawsuit Alleges

Xarelto Advertisements Failed to Disclose the Reality of Risks, Lawsuit Alleges

Many Xarelto lawsuits that have been filed against Johnson & Johnson and Bayer Corporation allege that the pharmaceutical companies failed to... Read More

Will Praxbind Reign as a Safe Antidote to Pradaxa?

Will Praxbind Reign as a Safe Antidote to Pradaxa?

Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the... Read More

What Can We Do About Risperdal’s Side Effects?

What Can We Do About Risperdal’s Side Effects?

Last month, Huffington Post published a 58,000 word series on Johnson & Johnson’s illegal marketing of the dangerous drug Risperdal.... Read More

Recent Xarelto Study Reveals Drug Manufacturer Agenda to Minimize Reports of Deaths and Injuries

Recent Xarelto Study Reveals Drug Manufacturer Agenda to Minimize Reports of Deaths and Injuries

Jasnssen Pharmaceuticals, Inc. published a recent study on the safety of Xarelto, where the drug manufacturer attempted to minimize the injuries... Read More